Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Moolec Science SA (MLEC)

Avenue Therapeutics, Inc. and Moolec Science SA are both Biotechnology companies. Avenue Therapeutics, Inc. and Moolec Science SA are of similar size ($680.0K and $620.0K). Avenue Therapeutics, Inc. has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Avenue Therapeutics, Inc. leads on 6 and Moolec Science SA on 6.

Valuation

Metric ATXI MLEC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.03 9.40
P/B 2.49 0.01 2.13
Price to free cash flow n/m 0.01 25.18
EV/EBITDA 0.05 1.76 0.66
EV/Sales n/m 8.37 9.02
Earnings yield (197.67%) (3,822.12%) (32.88%)
Free cash flow yield (97.68%) 8,301.70% (23.13%)

Profitability

Metric ATXI MLEC Biotechnology median
Gross margin — 2,373.25% 68.51%
Operating margin 0.00% 244.93% 0.00%
Net margin 0.00% (105.71%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 0.00% (51.96%)
Return on assets (90.50%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI MLEC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.11% (793.17%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI MLEC Biotechnology median
Debt to equity 0.00 4.37 0.00
Current ratio 1.40 0.15 4.97
Net debt to EBITDA 0.93 (2.73) 1.01

Dividend

Metric ATXI MLEC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATXI MLEC Biotechnology median
Market cap 680.00k 620.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack